0719

In this month’s issue, our gallery special feature makes its return with some of the weird and wonderful artwork that lights up the laboratory. From stunning slide images to abstract digital representations, we celebrate the visual nature of pathology and laboratory medicine by showcasing your best submissions. In addition, Alessandro Lugli explores the potential of tumor budding as a novel histopathological biomarker, Aadil Ahmed and Kamran Mirza make the case that pathology should be considered a clinical discipline, and Richard Levenson discusses the lessons he has learned throughout a successful career in the lab. We also sit down with David Wilbur, Former Director of Cytopathology and Clinical Imaging at Massachusetts General Hospital and current Chief Medical Scientist at Corista LLC, USAK.

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online

Articles featured in this issue

Diagnostics Histology

Case of the Month

07/02/2019

Can you diagnose this 77-year-old man who presented with an arcuate, erythematous patch on his lower back?

Inside the Lab Microscopy and imaging

From the Ridiculous to the Sublime

06/28/2019 | Michael Schubert

Our gallery showcase is about more than just publishing pretty pictures – it highlights art’s vital importance in a visual discipline.

Subspecialties Microbiology and immunology

A Meaningful Microbiome

07/05/2019 | Michael Schubert

The microbial diversity and species distribution of the cervix may help diagnosticians determine the patients at increased risk of cervical cancer.

Diagnostics Omics

A Microbial Map to Cancer

06/27/2019 | Michael Schubert

A new study uses machine learning to perform meta-analysis of eight metagenomic studies linking gut microbial signatures with colorectal cancer.

Outside the Lab Point of care testing

To POCT or Not to POCT?

07/02/2019 | Michael Schubert

Many previously laboratory-based tests now have rapid and reliable POCT alternatives – and primary care providers should be encouraged to use them.

Diagnostics Companion diagnostics

Welcome to Our Kitchen

07/04/2019 | David L. Rimm

David Rimm challenges the sensitivity and reproducibility of a new assay for PD-L1 detection.

Diagnostics Companion diagnostics

Improving Patient Outcomes

07/04/2019 | Eslie Dennis, Eric Walk, Ken Bloom, Mark Kockx

A response to David Rimm’s letter that supports the role of PD-L1 testing in improving outcomes for cancer patients.

Inside the Lab Laboratory management

Fostering Quality

07/01/2019 | E. Blair Holladay

No investment is more important for laboratory quality and patient care than investment in laboratory personnel.

Subspecialties Microscopy and imaging

The Picture of Health

07/03/2019 | Michael Schubert

From stunning slide images to abstract representations of bodily functions, discover pathology and laboratory medicine’s most enticing visuals.

Subspecialties Histology

The Heavy Cavalry of Colorectal Cancer

06/18/2019 | Alessandro Lugli

What is tumor budding – and how can this novel histopathological biomarker better stratify colorectal cancer patients?

Inside the Lab Liquid biopsy

CTCs in a Spin

05/31/2019 | Luke Turner

A microfluidic device reveals new insights into the function of circulating tumor cells, providing vital information on how cancers metastasize.

Diagnostics Liquid biopsy

Fine-Tuning Immunotherapy

06/27/2019 | George Karlin-Neumann

Techniques like droplet digital PCR technology can assist with early monitoring of cancer immunotherapy to ensure the right treatment for each patient